"The cystic fibrosis (CF) drug Orkambi (Vertex Pharmaceuticals) has received a green light from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP).
Orkambi is a fixed-dose oral combination "...
VisionBlue Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
VisionBlue (trypan blue) Ophthalmic Solution is a selective tissue staining agent used as an aid in ophthalmic surgery by staining the anterior capsule of the lens. Common side effects include temporary blue coloration of the eye, and staining of implanted lenses.
VisionBlue is packaged in a 2.25 mL dose syringe to which a blunt cannula has to be attached. VisionBlue may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, VisionBlue should be used only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
Our VisionBlue (trypan blue) Ophthalmic Solution Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
VisionBlue FDA Prescribing Information: Side Effects
Adverse reactions reported following use of VisionBlue® (trypan blue) include discoloration of high water content hydrogen intraocular lenses (see CONTRAINDICATIONS) and inadvertent staining of the posterior lens capsule and vitreous face. Staining of the posterior lens capsule or staining of the vitreous face is generally self limited, lasting up to one week.
Read the entire FDA prescribing information for VisionBlue (Trypan Blue)
Additional VisionBlue Information
Report Problems to the Food and Drug Administration
Find out what women really need.